Human CD4(+) T cells specific for dominant epitopes of SARS‐CoV‐2 Spike and Nucleocapsid proteins with therapeutic potential

Since December 2019, Coronavirus disease‐19 (COVID‐19) has spread rapidly throughout the world, leading to a global effort to develop vaccines and treatments. Despite extensive progress, there remains a need for treatments to bolster the immune responses in infected immunocompromised individuals, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhagen, Johan, van der Meijden, Edith D., Lang, Vanessa, Kremer, Andreas E., Völkl, Simon, Mackensen, Andreas, Aigner, Michael, Kremer, Anita N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239517/
https://www.ncbi.nlm.nih.gov/pubmed/34061349
http://dx.doi.org/10.1111/cei.13627

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239517/
https://www.ncbi.nlm.nih.gov/pubmed/34061349
http://dx.doi.org/10.1111/cei.13627

Ejemplares similares